Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab
PHASE2
This phase II trial studies how well daratumumab, azacitidine, and dexameth...
Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation
PHASE2
The goal of this clinical research study is to learn if 5-azacitidine and s...
Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
PHASE2
This phase II trial tests how well venetoclax with cladribine and cytarabin...
Status
Recruiting
Location
University of Miami Miller School of Medicine-Sylvester Cancer Center